4426.0 Global Capital, Big Pharma and the Deformation of Medical Practice

Tuesday, October 30, 2012: 4:30 PM - 6:00 PM
Oral
This session will review and update some of the corporate misbehavior that is common in the marketing and production of pharmaceuticals.
Organizers:
Johnathon Samuel Ross, MD MPH and Martha Livingston, PhD
Moderator:
Linnea Capps, MD,MPH

4:30pm
Role of global pharmaceutical companies in worsening public health by expanding criteria and creating new categories for people given prescription drugs
Donald Light, PhD
4:50pm
Corporate shaping of basic public health definitions including disease entities and primary prevention
Beatrice Manning, PhD
     
5:10pm
From development to withdrawal of Raptiva: A case study examining conflicts of interest in pharma-FDA relationships, inadequate safety studies, and circumvention of the physician intermediary
David Egilman, MD, MPH and Caroline Lee, BS

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Socialist Caucus
Endorsed by: Labor Caucus, Alcohol, Tobacco, and Other Drugs, Chiropractic Health Care

See more of: Socialist Caucus
<< Previous Session | Next Session >>